'Supplementary figure 1' diaporamas de présentation

Supplementary figure 1 - PowerPoint PPT Presentation


Supplementary Figures 1-3

Supplementary Figures 1-3

Supplementary Figures 1-3 The protein tyrosine-phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis Kathleen Spring 1# , Patrick Fournier 1# , Line Lapointe 1 , Catherine Chabot 1 , Jacinthe Roussy 1 , Sandra Pommey 1 , John Stagg 1, 2 , and Isabelle Royal 1, 3

By tab
(265 views)

Supplementary figure 1

Supplementary figure 1

Dorsal administration of 1% DNCB. Oral / Dorsal administration of C6. 8. 3. 7. Week s 0. 1. 5. 6. 2. 4. Dorsal administration of 0.3% DNCB. Supplementary figure 1.

By misu
(48 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1.

By idra
(52 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1. A. rate of PDPN expression. CAF4: PDPN. 13.48%. 14.38%. CAF1. Time of trypsin/EDTA treatment (min). B. Cultured CAFs. CTRL. 2min. 13.87%. CAF2. CAF3. CAF4. CAF1. CAF3. CAF4. CAF2. Harvested CAFs. 5min. 10min. CAF1. CAF3. CAF4. CAF2. C.

By infinity
(98 views)

Supplementary Figure 1

Supplementary Figure 1

i. ii. iii. iv. Supplementary Figure 1.

By aquila
(51 views)

GSTPi

GSTPi

clones. mass cultures. BMhTERT-1. BMhTERT-2. BM2A2. BM2B8. BM2A7. BM2A11. BM2B2. BM2A6. BM2A10. BM10A3. BM2A9. BM10B1. BM2B12. BMEC. p16 INK4a + + + + - + + + + + + + - - - -. kDa. 23. GSTPi. 42. Actin.

By neva
(116 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1. a. d. BMDM. BMDM. b. BMDM. e. BMDM. c. BMDM.

By dunn
(65 views)

polyI:C

polyI:C

polyI:C. CpG. LPS. 0.32. 2.35. 0.92. 3.04. 0.83. 2.09. SSC. 95. 2.36. 92.8. 3.22. 95.2. 1.89. untreated. 0.65. 2.69. PI. 95.1. 1.56. A. polyI:C. CpG. LPS. untreated. 72.7. 66.1. 65.8. 69.6. FSC. B. Annexin V. Supplementary Figure 1

By teddy
(145 views)

Trapped allele

Trapped allele

Supplementary Figure 1. frt. F3. frt. F3. lx5171. lxP. lxP. lx5171. E1. OPE. OPE. OPE. OPE. OPE. OPE. E2. pA. SA. b geo. pA. inversion at F3 sites. inversion at frt sites. E1. E2. pA. OPE. OPE. OPE. OPE. OPE. OPE. SA. b geo. pA. Inversion by FLP. E1. OPE. OPE.

By tyne
(92 views)

Supplementary figure 1

Supplementary figure 1

Supplementary figure 1. Viable. Viable. Apoptotic. Apoptotic. Necrotic. Necrotic. 120. SKOV-3. 100. 80. 60. % total number of cells. 40. 20. 0. 0 hr. 24 hr. 48 hr. 72 hr. 96 hr. - 22 kDa. WB:. - 15 kDa. α Bid α G3PDH. - 37 kDa. Caov-4. SKOV-3. A. 120. Caov-4. 100.

By ella
(69 views)

Supplementary Figure 1

Supplementary Figure 1

Nephrin. Nephrin. Nephrin. Nephrin. Nephrin. Synaptopodin. Synaptopodin. Synaptopodin. Synaptopodin. Synaptopodin. A. Merge. Merge. Merge. Merge. Merge. B. Podocin. Podocin. Podocin. Podocin. Podocin. Day 28. Control. Day 3. Day 15. Day 7. ADRN 11 mg/kg. Cont. Day3.

By les
(52 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1. HUVEC. A549. ACHN. DU145. kDa. - 150. NRP1. - 102. - 150. NRP2. - 102. - 225. VEGFR-1. - 150. - 225. VEGFR-2. - 150. - 38. GAPDH. - 31. NRP1. GAPDH. Supplementary Figure 2. C. siRNA. C. #4914. #4820. kDa. - 150. - 102. - 38. - 31.

By tirza
(74 views)

CD3

CD3

Supplementary Figure 1. C5aR-/- to C5aR-/-. WT to WT. CD3. Gr-1.

By eunice
(124 views)

7AAD

7AAD

Overlay. 7AAD. Myosin heavy chain. S3RNAi treated. Controls. Supplementary figure 1. myosin heavy chain protein levels ( reen ) in S3RNAi treated C2C12 cells is decreased in comparison to controls after 72 h in DM. Nuclei were counter-stained with 7-AAD (red).

By cullen
(136 views)

Supplementary Figure 1. Heat map using Ingenuity Analysis

Supplementary Figure 1. Heat map using Ingenuity Analysis

Supplementary Figure 1. Heat map using Ingenuity Analysis s oftware and the “Cell Signaling” category. The range of difference b etween DU145 and DU145LN4 groups are 1.8-16.4 fold. relative. min. max.

By dympna
(81 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1. A. B. C. D. E. A: 0. B: 1+. C: 2+. D: 3+. E: Normal bronchial epithelium. Supplementary Table 1. Summary of Tumors with Intrinsic Resistance.

By dougal
(151 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1. Kantidakis and White. 400ng. 200ng. 100ng. RNA:. Dr1 mRNA. 5S rRNA. pre-tRNA LEU. pre-tRNA TYR. tRNA Met. Alu RNA. 7SL RNA. U6 snRNA. ARPP P0 mRNA. Repression of tRNA genes by Dr1. Supplementary Figure 2. Kantidakis and White. A. Dr1 RNAi. control.

By jalena
(85 views)

Control (MAAII) Sialidase (MAAII) Buffer (MAAII)

Control (MAAII) Sialidase (MAAII) Buffer (MAAII)

Supplementary Figure 1. ATI-like. ATII. AMs. PBDMs. A. b. a. c. d. Control (MAAII) Sialidase (MAAII) Buffer (MAAII). e. f. g. h. i. j. k. l. Supplementary Figure 1. ATI-like. ATII. AMs. PBDMs. B. b. a. c. d. Control (SNA) Sialidase (SNA) Buffer (SNA). e. f.

By nitara
(64 views)

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 1. A. MIG (pMSCV-ires-GFP). I. GFP. LTR. LTR. MIG-PL2 (pMSCV-PLAGL2-ires-GFP). PL2. GFP. LTR. LTR. I. B. CBFb-MYH11 + HPs. GFP sort. Gene expression profile. Genes commonly deregulated in PL2+ cells. MIG-PL2 transduction. MIG transduction. GFP sort.

By andie
(106 views)

Raw264.7

Raw264.7

Raw264.7. ***.

By cece
(105 views)

View Supplementary figure 1 PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Supplementary figure 1 PowerPoint presentations. You can view or download Supplementary figure 1 presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.